EVOKE PHARMA, INC. Operating Lease Right-of-Use Assets
EVOKE PHARMA, INC. had Operating Lease Right-of-Use Assets of $106.71 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-13
- 2025-09-30: Operating Lease, Right-of-Use Asset $106.71K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $122.94K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $138.76K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $154.18K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $106.71K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $122.94K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $138.76K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $154.18K 10-Q · filed 2025-11-13 |
| 2023-09-30 | $13.37K 10-K/A · filed 2024-05-14 |
| 2023-06-30 | $52.84K 10-K/A · filed 2024-05-14 |
| 2023-03-31 | $91.40K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $129.07K 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $153.67K 10-Q · filed 2022-11-09 |
| 2021-12-31 | $12.43K 10-K · filed 2023-03-21 |
| 2021-09-30 | $49.12K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $84.93K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $119.93K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $141.71K 10-K · filed 2022-03-08 |
| 2020-09-30 | $36.12K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $71.21K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $105.35K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $138.54K 10-K · filed 2021-03-11 |
| 2019-09-30 | $35.40K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $69.80K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $103.25K 10-Q · filed 2019-05-08 |
| 2019-01-01 | $136.00K 10-K · filed 2020-03-12 |